Page last updated: 2024-12-07

5-hydroxydopamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-hydroxydopamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114772
CHEMBL ID30625
CHEMBL ID535194
CHEBI ID89485
SCHEMBL ID328576
MeSH IDM0090073

Synonyms (25)

Synonym
1927-04-4
5-(2-aminoethyl)-pyrogallol
5-hydroxydopamine
CHEMBL30625
chebi:89485 ,
3,4,5-trihydroxyphenethylamine
5-(2-aminoethyl)benzene-1,2,3-triol hydrochloride
bdbm50234649
CHEMBL535194 ,
5-(2-aminoethyl)benzene-1,2,3-triol
AKOS006228695
5-(2-aminoethyl)-1,2,3-benzenetriol
1,2,3-benzenetriol, 5-(2-aminoethyl)-
SCHEMBL328576
5-(2-amino-ethyl)-benzene-1,2,3-triol
5-(2-aminoethyl)-1,2,3-benzenetriol #
trihydroxyphenethylamine, 3,4,5-
DTXSID50172862
5-(2-aminoethyl)1,2,3-benzenetriol
3,4,5-trihydroxyphenylethylamine
Q27161678
pyrogallol, 5-(2-aminoethyl)-
hydroxydopamine, 5-
VH3HUU3DNN
PD101872
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
catecholamine4-(2-Aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] and derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID215613Dissociation constant against a series of agonists of membranes of the turkey erythrocyte containing mainly Beta adrenergic receptor was determined1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
Correlation between affinity toward adrenergic receptors and approximate electrostatic potentials of phenylethylamine derivatives. 1. Effects of the side chain.
AID588208Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset2010Molecular pharmaceutics, Oct-04, Volume: 7, Issue:5
Predicting phospholipidosis using machine learning.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (70)

TimeframeStudies, This Drug (%)All Drugs %
pre-199039 (55.71)18.7374
1990's20 (28.57)18.2507
2000's10 (14.29)29.6817
2010's1 (1.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.13 (24.57)
Research Supply Index4.28 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index25.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other70 (98.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]